NCT00081042View on ClinicalTrials.gov

ABI-007 in Treating Patients With Inoperable Locally Recurrent or Metastatic Melanoma

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

February 29, 2004

Study Completion Date

January 31, 2010

Conditions
Melanoma (Skin)
Interventions
DRUG

paclitaxel albumin-stabilized nanoparticle formulation

Trial Locations (1)

90095-1781

Jonsson Comprehensive Cancer Center at UCLA, Los Angeles

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Jonsson Comprehensive Cancer Center

OTHER

NCT00081042 - ABI-007 in Treating Patients With Inoperable Locally Recurrent or Metastatic Melanoma | Biotech Hunter | Biotech Hunter